Kimon Bekelis1, Symeon Missios2, Todd A MacKenzie3, Nicos Labropoulos4, David W Roberts5. 1. Section of Neurosurgery, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA. 2. Department of Neurosurgery, Cleveland Clinic, Cleveland, Ohio, USA. 3. Department of Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA Department of Community and Family Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA The Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, New Hampshire, USA. 4. Section of Vascular Surgery, SUNY Stony Brook, Stony Brook, New York, USA. 5. Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA Department of Neurology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA.
Abstract
BACKGROUND: Cost containment is the cornerstone of the Affordable Care Act. Although studies have compared the cost of cerebral aneurysm clipping (CAC) and coiling, they have not focused on identification of drivers of cost after CAC, or prediction of its magnitude. The objective of the present study was to develop and validate a predictive model of hospitalization cost after CAC. METHODS: We performed a retrospective study involving CAC patients who were registered in the Nationwide Inpatient Sample (NIS) database from 2005 to 2010. The two cohorts of ruptured and unruptured aneurysms underwent 1:1 randomization to create derivation and validation subsamples. Regression techniques were used for the creation of a parsimonious predictive model. RESULTS: Of the 7798 patients undergoing CAC, 4505 (58%) presented with unruptured and 3293 (42%) with ruptured aneurysms. Median hospitalization cost was US$24,398 (IQR $17,079 to $38,249) and $73,694 (IQR $46,270 to $115,128) for the two cohorts, respectively. Common drivers of cost identified in the multivariate analyses included the following: length of stay, number of admission diagnoses and procedures, hospital size and region, and patient income. The models were validated in independent cohorts and demonstrated final R(2) values very similar to the initial models. The predicted and observed values in the validation cohort demonstrated good correlation. CONCLUSIONS: This national study identified significant drivers of hospitalization cost after CAC. The presented model can be utilized as an adjunct in the cost containment debate and the creation of data driven policies. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
BACKGROUND: Cost containment is the cornerstone of the Affordable Care Act. Although studies have compared the cost of cerebral aneurysm clipping (CAC) and coiling, they have not focused on identification of drivers of cost after CAC, or prediction of its magnitude. The objective of the present study was to develop and validate a predictive model of hospitalization cost after CAC. METHODS: We performed a retrospective study involving CAC patients who were registered in the Nationwide Inpatient Sample (NIS) database from 2005 to 2010. The two cohorts of ruptured and unruptured aneurysms underwent 1:1 randomization to create derivation and validation subsamples. Regression techniques were used for the creation of a parsimonious predictive model. RESULTS: Of the 7798 patients undergoing CAC, 4505 (58%) presented with unruptured and 3293 (42%) with ruptured aneurysms. Median hospitalization cost was US$24,398 (IQR $17,079 to $38,249) and $73,694 (IQR $46,270 to $115,128) for the two cohorts, respectively. Common drivers of cost identified in the multivariate analyses included the following: length of stay, number of admission diagnoses and procedures, hospital size and region, and patient income. The models were validated in independent cohorts and demonstrated final R(2) values very similar to the initial models. The predicted and observed values in the validation cohort demonstrated good correlation. CONCLUSIONS: This national study identified significant drivers of hospitalization cost after CAC. The presented model can be utilized as an adjunct in the cost containment debate and the creation of data driven policies. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Authors: Elliott S Fisher; David E Wennberg; Thérèse A Stukel; Daniel J Gottlieb; F L Lucas; Etoile L Pinder Journal: Ann Intern Med Date: 2003-02-18 Impact factor: 25.391
Authors: Jane Wolstenholme; Oliver Rivero-Arias; Alastair Gray; Andrew J Molyneux; Richard S C Kerr; Julia A Yarnold; Mary Sneade Journal: Stroke Date: 2007-11-29 Impact factor: 7.914
Authors: Alberto Maud; Kamakshi Lakshminarayan; M Fareed K Suri; Gabriela Vazquez; Giuseppe Lanzino; Adnan I Qureshi Journal: J Neurosurg Date: 2009-05 Impact factor: 5.115
Authors: Kimon Bekelis; Daniel J Gottlieb; Yin Su; Giuseppe Lanzino; Michael T Lawton; Todd A MacKenzie Journal: J Neurosurg Date: 2016-05-20 Impact factor: 5.115
Authors: William C Johnson; Nicolas A Morton-Gonzaba; John V Lacci; Daniel Godoy; Alireza Mirahmadizadeh; Ali Seifi Journal: Neurocrit Care Date: 2019-04 Impact factor: 3.210
Authors: Hai Sun; Piyush Kalakoti; Kanika Sharma; Jai Deep Thakur; Rimal H Dossani; Devi Prasad Patra; Kevin Phan; Hesam Akbarian-Tefaghi; Frank Farokhi; Christina Notarianni; Bharat Guthikonda; Anil Nanda Journal: PLoS One Date: 2017-10-27 Impact factor: 3.240